on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Position in Mural Oncology
The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc under Irish Takeover Panel regulations. The disclosure, dated 09 October 2025, outlines Vanguard's interests in Mural Oncology's $0.01 ordinary shares, amounting to 288,843 shares, representing 1.67% shareholding.
The form 8.3 submission specifies that there are no additional interests or positions beyond these holdings. Vanguard's recent transaction involved a purchase of 16 of these ordinary shares at a price of 2.08 USD each.
No cash-settled or stock-settled derivatives are reported in association with this disclosure. Additionally, no indemnity or option agreements related to Mural Oncology's securities exist, per Vanguard's statement.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news